Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy

Cerebral Palsy Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00473161
• Other study ID #: EMG biofeedback
• Status: Completed
• Phase: Phase 1/Phase 2
• First received: May 11, 2007
• Last updated: May 21, 2014
• Start date: May 2007

Study information

• Verified date: May 2014
• Source: University of Southern California
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

A newly-developed device for biofeedback of surface EMG will be used to either increase or decrease activity in the muscles of children with poor reaching due to cerebral palsy.

Description:

Children ages newborn to 21 with a diagnosis of arm weakness, hypertonia, or hyperkinesia due to cerebral palsy will be recruited. A muscle that is either over-active or under-active will be selected for each child. The child will be provided with the device to wear for 1 month in order to call attention to the identified muscle. At the beginning and end of the month, reaching will be assessed using three-dimensional kinematic motion capture. The outcome measure will be the speed and curvature of reaching to a target in front of the child.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. primary completion date: January 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 1 Month to 21 Years

Eligibility

Inclusion Criteria:

• weakness, hypertonia, or hyperkinetic disorder affecting one or both arms

• reduced speed or quality of reaching

Exclusion Criteria:

• any condition that would increase the risk of participation

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Cerebral Palsy
• Hypertonia
• Weakness

Intervention

Device:
• surface EMG biofeedback

Locations

Country	Name	City	State
United States	Stanford University	Stanford	California

Sponsors (1)

Lead Sponsor	Collaborator
University of Southern California

Country where clinical trial is conducted

United States,